nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—coronary artery disease	0.487	0.702	CbGaD
Amlexanox—PDE4B—coronary artery disease	0.207	0.298	CbGaD
Amlexanox—FGF1—artery—coronary artery disease	0.00387	0.102	CbGeAlD
Amlexanox—IL3—blood—coronary artery disease	0.00364	0.0957	CbGeAlD
Amlexanox—FGF1—endothelium—coronary artery disease	0.00327	0.086	CbGeAlD
Amlexanox—Throat sore—Penbutolol—coronary artery disease	0.00325	0.0386	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Penbutolol—coronary artery disease	0.00322	0.0383	CcSEcCtD
Amlexanox—S100A13—Captopril—Enalapril—coronary artery disease	0.00276	0.766	CbGdCrCtD
Amlexanox—Oropharyngeal pain—Penbutolol—coronary artery disease	0.00258	0.0306	CcSEcCtD
Amlexanox—Aphthous stomatitis—Captopril—coronary artery disease	0.00249	0.0296	CcSEcCtD
Amlexanox—S100A13—heart—coronary artery disease	0.00232	0.0609	CbGeAlD
Amlexanox—S100A12—heart—coronary artery disease	0.00229	0.0601	CbGeAlD
Amlexanox—S100A13—cardiovascular system—coronary artery disease	0.00219	0.0574	CbGeAlD
Amlexanox—FGF1—cardiac ventricle—coronary artery disease	0.00217	0.0571	CbGeAlD
Amlexanox—S100A12—cardiovascular system—coronary artery disease	0.00216	0.0567	CbGeAlD
Amlexanox—FGF1—myocardium—coronary artery disease	0.00204	0.0537	CbGeAlD
Amlexanox—S100A12—blood—coronary artery disease	0.00171	0.0448	CbGeAlD
Amlexanox—Throat sore—Enalapril—coronary artery disease	0.00169	0.0201	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Enalapril—coronary artery disease	0.00168	0.0199	CcSEcCtD
Amlexanox—PDE4D—heart—coronary artery disease	0.00153	0.0401	CbGeAlD
Amlexanox—FGF1—heart—coronary artery disease	0.00143	0.0375	CbGeAlD
Amlexanox—PDE4A—heart—coronary artery disease	0.00135	0.0355	CbGeAlD
Amlexanox—FGF1—cardiovascular system—coronary artery disease	0.00135	0.0354	CbGeAlD
Amlexanox—Oropharyngeal pain—Enalapril—coronary artery disease	0.00134	0.0159	CcSEcCtD
Amlexanox—Liver function test abnormal—Gemfibrozil—coronary artery disease	0.00134	0.0159	CcSEcCtD
Amlexanox—Throat sore—Timolol—coronary artery disease	0.00124	0.0147	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Timolol—coronary artery disease	0.00123	0.0146	CcSEcCtD
Amlexanox—PDE4B—cardiac ventricle—coronary artery disease	0.00123	0.0322	CbGeAlD
Amlexanox—FGF1—cardiac atrium—coronary artery disease	0.00122	0.0321	CbGeAlD
Amlexanox—PDE4B—myocardium—coronary artery disease	0.00115	0.0303	CbGeAlD
Amlexanox—Throat sore—Lisinopril—coronary artery disease	0.00115	0.0136	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Lisinopril—coronary artery disease	0.00114	0.0135	CcSEcCtD
Amlexanox—FGF1—blood—coronary artery disease	0.00106	0.028	CbGeAlD
Amlexanox—Liver function test abnormal—Fenofibrate—coronary artery disease	0.00102	0.0121	CcSEcCtD
Amlexanox—Pain—Tirofiban—coronary artery disease	0.00101	0.012	CcSEcCtD
Amlexanox—Liver function test abnormal—Clopidogrel—coronary artery disease	0.00101	0.0119	CcSEcCtD
Amlexanox—Oropharyngeal pain—Timolol—coronary artery disease	0.000981	0.0116	CcSEcCtD
Amlexanox—Liver function test abnormal—Ezetimibe—coronary artery disease	0.00098	0.0116	CcSEcCtD
Amlexanox—Oropharyngeal pain—Lisinopril—coronary artery disease	0.00091	0.0108	CcSEcCtD
Amlexanox—Liver function test abnormal—Niacin—coronary artery disease	0.000858	0.0102	CcSEcCtD
Amlexanox—Liver function test abnormal—Pravastatin—coronary artery disease	0.000845	0.01	CcSEcCtD
Amlexanox—S100A13—Alprenolol—Penbutolol—coronary artery disease	0.000843	0.234	CbGdCrCtD
Amlexanox—Liver function test abnormal—Trandolapril—coronary artery disease	0.00082	0.00974	CcSEcCtD
Amlexanox—Stomatitis—Clopidogrel—coronary artery disease	0.000818	0.00971	CcSEcCtD
Amlexanox—PDE4B—heart—coronary artery disease	0.000805	0.0211	CbGeAlD
Amlexanox—Headache—Tirofiban—coronary artery disease	0.000739	0.00877	CcSEcCtD
Amlexanox—Pain—Penbutolol—coronary artery disease	0.000715	0.00849	CcSEcCtD
Amlexanox—Nausea—Tirofiban—coronary artery disease	0.000701	0.00832	CcSEcCtD
Amlexanox—Nervous system disorder—Gemfibrozil—coronary artery disease	0.0007	0.00831	CcSEcCtD
Amlexanox—Stomatitis—Niacin—coronary artery disease	0.000698	0.00828	CcSEcCtD
Amlexanox—PDE4B—cardiac atrium—coronary artery disease	0.000688	0.0181	CbGeAlD
Amlexanox—Nervous system disorder—Ticagrelor—coronary artery disease	0.000684	0.00811	CcSEcCtD
Amlexanox—Stomatitis—Enalapril—coronary artery disease	0.000665	0.00789	CcSEcCtD
Amlexanox—Paraesthesia—Gemfibrozil—coronary artery disease	0.000641	0.0076	CcSEcCtD
Amlexanox—Stomatitis—Captopril—coronary artery disease	0.000637	0.00757	CcSEcCtD
Amlexanox—Headache—Pitavastatin—coronary artery disease	0.000631	0.00749	CcSEcCtD
Amlexanox—Paraesthesia—Ticagrelor—coronary artery disease	0.000626	0.00743	CcSEcCtD
Amlexanox—Stomatitis—Perindopril—coronary artery disease	0.000619	0.00735	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Gemfibrozil—coronary artery disease	0.000616	0.00731	CcSEcCtD
Amlexanox—Nervous system disorder—Rosuvastatin—coronary artery disease	0.000615	0.0073	CcSEcCtD
Amlexanox—Liver function test abnormal—Ramipril—coronary artery disease	0.000612	0.00726	CcSEcCtD
Amlexanox—Pain—Gemfibrozil—coronary artery disease	0.00061	0.00724	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Ticagrelor—coronary artery disease	0.000602	0.00714	CcSEcCtD
Amlexanox—PDE4B—blood—coronary artery disease	0.0006	0.0158	CbGeAlD
Amlexanox—Nausea—Pitavastatin—coronary artery disease	0.000598	0.0071	CcSEcCtD
Amlexanox—Liver function test abnormal—Timolol—coronary artery disease	0.000598	0.0071	CcSEcCtD
Amlexanox—Paraesthesia—Rosuvastatin—coronary artery disease	0.000563	0.00669	CcSEcCtD
Amlexanox—Pain—Rosuvastatin—coronary artery disease	0.000536	0.00637	CcSEcCtD
Amlexanox—Nervous system disorder—Fenofibrate—coronary artery disease	0.000534	0.00634	CcSEcCtD
Amlexanox—Nervous system disorder—Clopidogrel—coronary artery disease	0.000525	0.00623	CcSEcCtD
Amlexanox—Headache—Penbutolol—coronary artery disease	0.000524	0.00622	CcSEcCtD
Amlexanox—Nervous system disorder—Ezetimibe—coronary artery disease	0.000511	0.00607	CcSEcCtD
Amlexanox—Nervous system disorder—Eplerenone—coronary artery disease	0.000501	0.00594	CcSEcCtD
Amlexanox—Stomatitis—Ramipril—coronary artery disease	0.000498	0.00591	CcSEcCtD
Amlexanox—Nausea—Penbutolol—coronary artery disease	0.000497	0.0059	CcSEcCtD
Amlexanox—Paraesthesia—Fenofibrate—coronary artery disease	0.000489	0.0058	CcSEcCtD
Amlexanox—Paraesthesia—Clopidogrel—coronary artery disease	0.000481	0.0057	CcSEcCtD
Amlexanox—Paraesthesia—Lovastatin—coronary artery disease	0.000477	0.00567	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.00047	0.00558	CcSEcCtD
Amlexanox—Paraesthesia—Ezetimibe—coronary artery disease	0.000468	0.00556	CcSEcCtD
Amlexanox—Pain—Fenofibrate—coronary artery disease	0.000466	0.00553	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000462	0.00549	CcSEcCtD
Amlexanox—Nervous system disorder—Valsartan—coronary artery disease	0.000461	0.00547	CcSEcCtD
Amlexanox—Nervous system disorder—Olmesartan—coronary artery disease	0.000458	0.00544	CcSEcCtD
Amlexanox—Pain—Clopidogrel—coronary artery disease	0.000458	0.00543	CcSEcCtD
Amlexanox—Pain—Lovastatin—coronary artery disease	0.000455	0.0054	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.00045	0.00534	CcSEcCtD
Amlexanox—Headache—Gemfibrozil—coronary artery disease	0.000447	0.00531	CcSEcCtD
Amlexanox—Paraesthesia—Simvastatin—coronary artery disease	0.000447	0.0053	CcSEcCtD
Amlexanox—Pain—Ezetimibe—coronary artery disease	0.000446	0.00529	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000441	0.00523	CcSEcCtD
Amlexanox—Headache—Ticagrelor—coronary artery disease	0.000437	0.00518	CcSEcCtD
Amlexanox—Pain—Eplerenone—coronary artery disease	0.000436	0.00518	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000429	0.0051	CcSEcCtD
Amlexanox—Nervous system disorder—Trandolapril—coronary artery disease	0.000428	0.00508	CcSEcCtD
Amlexanox—Pain—Simvastatin—coronary artery disease	0.000425	0.00505	CcSEcCtD
Amlexanox—Nausea—Gemfibrozil—coronary artery disease	0.000424	0.00503	CcSEcCtD
Amlexanox—Paraesthesia—Valsartan—coronary artery disease	0.000422	0.00501	CcSEcCtD
Amlexanox—Nervous system disorder—Telmisartan—coronary artery disease	0.000421	0.00499	CcSEcCtD
Amlexanox—Nausea—Ticagrelor—coronary artery disease	0.000414	0.00491	CcSEcCtD
Amlexanox—Paraesthesia—Niacin—coronary artery disease	0.00041	0.00487	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000405	0.00481	CcSEcCtD
Amlexanox—Paraesthesia—Pravastatin—coronary artery disease	0.000404	0.00479	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000404	0.00479	CcSEcCtD
Amlexanox—Pain—Olmesartan—coronary artery disease	0.0004	0.00474	CcSEcCtD
Amlexanox—Nervous system disorder—Perindopril—coronary artery disease	0.000397	0.00471	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Niacin—coronary artery disease	0.000394	0.00468	CcSEcCtD
Amlexanox—Headache—Rosuvastatin—coronary artery disease	0.000393	0.00467	CcSEcCtD
Amlexanox—Paraesthesia—Trandolapril—coronary artery disease	0.000392	0.00465	CcSEcCtD
Amlexanox—Pain—Niacin—coronary artery disease	0.00039	0.00464	CcSEcCtD
Amlexanox—Paraesthesia—Enalapril—coronary artery disease	0.00039	0.00464	CcSEcCtD
Amlexanox—Nervous system disorder—Furosemide—coronary artery disease	0.000386	0.00458	CcSEcCtD
Amlexanox—Paraesthesia—Telmisartan—coronary artery disease	0.000385	0.00457	CcSEcCtD
Amlexanox—Pain—Pravastatin—coronary artery disease	0.000384	0.00456	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000377	0.00447	CcSEcCtD
Amlexanox—Paraesthesia—Captopril—coronary artery disease	0.000375	0.00445	CcSEcCtD
Amlexanox—Nausea—Rosuvastatin—coronary artery disease	0.000373	0.00442	CcSEcCtD
Amlexanox—Nervous system disorder—Losartan—coronary artery disease	0.000372	0.00442	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.00037	0.0044	CcSEcCtD
Amlexanox—Pain—Telmisartan—coronary artery disease	0.000367	0.00435	CcSEcCtD
Amlexanox—Paraesthesia—Perindopril—coronary artery disease	0.000364	0.00432	CcSEcCtD
Amlexanox—Nausea—Acetylsalicylic acid—coronary artery disease	0.000362	0.0043	CcSEcCtD
Amlexanox—Paraesthesia—Furosemide—coronary artery disease	0.000353	0.0042	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00035	0.00415	CcSEcCtD
Amlexanox—Pain—Perindopril—coronary artery disease	0.000346	0.00411	CcSEcCtD
Amlexanox—Headache—Fenofibrate—coronary artery disease	0.000341	0.00405	CcSEcCtD
Amlexanox—Paraesthesia—Losartan—coronary artery disease	0.000341	0.00405	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Furosemide—coronary artery disease	0.00034	0.00403	CcSEcCtD
Amlexanox—Pain—Furosemide—coronary artery disease	0.000337	0.004	CcSEcCtD
Amlexanox—Headache—Clopidogrel—coronary artery disease	0.000335	0.00398	CcSEcCtD
Amlexanox—Headache—Lovastatin—coronary artery disease	0.000333	0.00395	CcSEcCtD
Amlexanox—Headache—Ezetimibe—coronary artery disease	0.000327	0.00388	CcSEcCtD
Amlexanox—Pain—Losartan—coronary artery disease	0.000325	0.00386	CcSEcCtD
Amlexanox—Nausea—Fenofibrate—coronary artery disease	0.000323	0.00384	CcSEcCtD
Amlexanox—Headache—Eplerenone—coronary artery disease	0.00032	0.0038	CcSEcCtD
Amlexanox—Nervous system disorder—Ramipril—coronary artery disease	0.000319	0.00379	CcSEcCtD
Amlexanox—Nausea—Clopidogrel—coronary artery disease	0.000318	0.00377	CcSEcCtD
Amlexanox—Nausea—Lovastatin—coronary artery disease	0.000316	0.00375	CcSEcCtD
Amlexanox—Nervous system disorder—Timolol—coronary artery disease	0.000312	0.00371	CcSEcCtD
Amlexanox—Headache—Simvastatin—coronary artery disease	0.000312	0.0037	CcSEcCtD
Amlexanox—Nausea—Ezetimibe—coronary artery disease	0.00031	0.00368	CcSEcCtD
Amlexanox—Nausea—Eplerenone—coronary artery disease	0.000303	0.0036	CcSEcCtD
Amlexanox—Nausea—Simvastatin—coronary artery disease	0.000295	0.00351	CcSEcCtD
Amlexanox—Headache—Valsartan—coronary artery disease	0.000294	0.00349	CcSEcCtD
Amlexanox—Headache—Olmesartan—coronary artery disease	0.000293	0.00348	CcSEcCtD
Amlexanox—Paraesthesia—Ramipril—coronary artery disease	0.000292	0.00347	CcSEcCtD
Amlexanox—Headache—Niacin—coronary artery disease	0.000286	0.0034	CcSEcCtD
Amlexanox—Paraesthesia—Timolol—coronary artery disease	0.000286	0.00339	CcSEcCtD
Amlexanox—Headache—Pravastatin—coronary artery disease	0.000282	0.00334	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000281	0.00334	CcSEcCtD
Amlexanox—Nausea—Valsartan—coronary artery disease	0.000279	0.00331	CcSEcCtD
Amlexanox—Nausea—Olmesartan—coronary artery disease	0.000278	0.0033	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Timolol—coronary artery disease	0.000275	0.00326	CcSEcCtD
Amlexanox—Headache—Trandolapril—coronary artery disease	0.000274	0.00325	CcSEcCtD
Amlexanox—Headache—Enalapril—coronary artery disease	0.000272	0.00323	CcSEcCtD
Amlexanox—Pain—Timolol—coronary artery disease	0.000272	0.00323	CcSEcCtD
Amlexanox—Nausea—Niacin—coronary artery disease	0.000271	0.00322	CcSEcCtD
Amlexanox—Headache—Telmisartan—coronary artery disease	0.000269	0.00319	CcSEcCtD
Amlexanox—Nausea—Pravastatin—coronary artery disease	0.000267	0.00317	CcSEcCtD
Amlexanox—Paraesthesia—Lisinopril—coronary artery disease	0.000265	0.00315	CcSEcCtD
Amlexanox—Headache—Captopril—coronary artery disease	0.000261	0.0031	CcSEcCtD
Amlexanox—Nausea—Trandolapril—coronary artery disease	0.000259	0.00308	CcSEcCtD
Amlexanox—Nausea—Enalapril—coronary artery disease	0.000258	0.00307	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000255	0.00303	CcSEcCtD
Amlexanox—Nausea—Telmisartan—coronary artery disease	0.000255	0.00302	CcSEcCtD
Amlexanox—Headache—Perindopril—coronary artery disease	0.000254	0.00301	CcSEcCtD
Amlexanox—Pain—Lisinopril—coronary artery disease	0.000253	0.003	CcSEcCtD
Amlexanox—Nausea—Captopril—coronary artery disease	0.000248	0.00294	CcSEcCtD
Amlexanox—Headache—Furosemide—coronary artery disease	0.000247	0.00293	CcSEcCtD
Amlexanox—Nausea—Perindopril—coronary artery disease	0.000241	0.00286	CcSEcCtD
Amlexanox—Headache—Losartan—coronary artery disease	0.000238	0.00282	CcSEcCtD
Amlexanox—Nausea—Furosemide—coronary artery disease	0.000234	0.00278	CcSEcCtD
Amlexanox—Nausea—Losartan—coronary artery disease	0.000226	0.00268	CcSEcCtD
Amlexanox—Headache—Ramipril—coronary artery disease	0.000204	0.00242	CcSEcCtD
Amlexanox—Headache—Timolol—coronary artery disease	0.000199	0.00237	CcSEcCtD
Amlexanox—Nausea—Ramipril—coronary artery disease	0.000193	0.0023	CcSEcCtD
Amlexanox—Nausea—Timolol—coronary artery disease	0.000189	0.00224	CcSEcCtD
Amlexanox—Headache—Lisinopril—coronary artery disease	0.000185	0.0022	CcSEcCtD
Amlexanox—Nausea—Lisinopril—coronary artery disease	0.000175	0.00208	CcSEcCtD
Amlexanox—PDE4D—Signaling Pathways—C3—coronary artery disease	7.3e-06	4.06e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL8—coronary artery disease	7.28e-06	4.05e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NFKBIA—coronary artery disease	7.28e-06	4.05e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PPP2CA—coronary artery disease	7.24e-06	4.03e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6R—coronary artery disease	7.24e-06	4.03e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP3—coronary artery disease	7.22e-06	4.01e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT5A—coronary artery disease	7.22e-06	4.01e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK1—coronary artery disease	7.2e-06	4.01e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CSF2—coronary artery disease	7.2e-06	4e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF1—coronary artery disease	7.2e-06	4e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—KIT—coronary artery disease	7.2e-06	4e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LPL—coronary artery disease	7.14e-06	3.97e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PRKCD—coronary artery disease	7.11e-06	3.96e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AKT1—coronary artery disease	7.11e-06	3.95e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RPS6KB1—coronary artery disease	7.08e-06	3.94e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MEF2C—coronary artery disease	7.08e-06	3.94e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KIT—coronary artery disease	7.05e-06	3.92e-05	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—coronary artery disease	7.04e-06	3.92e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOB—coronary artery disease	6.98e-06	3.88e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HIF1A—coronary artery disease	6.97e-06	3.87e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HTR2A—coronary artery disease	6.96e-06	3.87e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—C3—coronary artery disease	6.95e-06	3.87e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AGT—coronary artery disease	6.94e-06	3.86e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—GSK3B—coronary artery disease	6.91e-06	3.84e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ITGB3—coronary artery disease	6.9e-06	3.84e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EDN1—coronary artery disease	6.87e-06	3.82e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CREB1—coronary artery disease	6.85e-06	3.81e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL5—coronary artery disease	6.81e-06	3.79e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOE—coronary artery disease	6.8e-06	3.78e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LEP—coronary artery disease	6.8e-06	3.78e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GSK3B—coronary artery disease	6.76e-06	3.76e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL8—coronary artery disease	6.74e-06	3.75e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOA1—coronary artery disease	6.72e-06	3.74e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CSF2—coronary artery disease	6.71e-06	3.73e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—coronary artery disease	6.71e-06	3.73e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CREB1—coronary artery disease	6.71e-06	3.73e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PPP2CA—coronary artery disease	6.7e-06	3.73e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6R—coronary artery disease	6.68e-06	3.72e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LPL—coronary artery disease	6.66e-06	3.71e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KDR—coronary artery disease	6.66e-06	3.71e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HIF1A—coronary artery disease	6.63e-06	3.69e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK14—coronary artery disease	6.62e-06	3.68e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AGT—coronary artery disease	6.61e-06	3.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MEF2C—coronary artery disease	6.6e-06	3.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RPS6KB1—coronary artery disease	6.6e-06	3.67e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PRKCD—coronary artery disease	6.58e-06	3.66e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—coronary artery disease	6.58e-06	3.66e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL2—coronary artery disease	6.57e-06	3.65e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF2—coronary artery disease	6.56e-06	3.65e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6R—coronary artery disease	6.55e-06	3.64e-05	CbGpPWpGaD
Amlexanox—IL3—Immune System—AKT1—coronary artery disease	6.49e-06	3.61e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ESR1—coronary artery disease	6.49e-06	3.61e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOE—coronary artery disease	6.47e-06	3.6e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LEP—coronary artery disease	6.47e-06	3.6e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1—coronary artery disease	6.45e-06	3.59e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HTR2A—coronary artery disease	6.44e-06	3.58e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ITGB3—coronary artery disease	6.43e-06	3.58e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—C3—coronary artery disease	6.43e-06	3.58e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAPK1—coronary artery disease	6.42e-06	3.57e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FN1—coronary artery disease	6.41e-06	3.57e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—F2—coronary artery disease	6.41e-06	3.57e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOA1—coronary artery disease	6.4e-06	3.56e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6ST—coronary artery disease	6.39e-06	3.55e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PIK3CA—coronary artery disease	6.37e-06	3.54e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KDR—coronary artery disease	6.34e-06	3.53e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NFKBIA—coronary artery disease	6.34e-06	3.52e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK14—coronary artery disease	6.3e-06	3.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—JAK2—coronary artery disease	6.29e-06	3.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—SERPINE1—coronary artery disease	6.26e-06	3.48e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PIK3CA—coronary artery disease	6.25e-06	3.48e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PPP2CA—coronary artery disease	6.25e-06	3.48e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—BCL2—coronary artery disease	6.23e-06	3.46e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ESR1—coronary artery disease	6.18e-06	3.44e-05	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—PIK3CA—coronary artery disease	6.14e-06	3.41e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PRKCD—coronary artery disease	6.14e-06	3.41e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KIT—coronary artery disease	6.14e-06	3.41e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HIF1A—coronary artery disease	6.13e-06	3.41e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SERPINE1—coronary artery disease	6.13e-06	3.41e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AGT—coronary artery disease	6.11e-06	3.4e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FN1—coronary artery disease	6.1e-06	3.39e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—F2—coronary artery disease	6.1e-06	3.39e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6ST—coronary artery disease	6.08e-06	3.38e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF2—coronary artery disease	6.06e-06	3.37e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—coronary artery disease	6.04e-06	3.36e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NFKBIA—coronary artery disease	6.03e-06	3.35e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HTR2A—coronary artery disease	6.01e-06	3.34e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PIK3CA—coronary artery disease	6e-06	3.34e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—C3—coronary artery disease	6e-06	3.34e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LEP—coronary artery disease	5.99e-06	3.33e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOE—coronary artery disease	5.99e-06	3.33e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—coronary artery disease	5.97e-06	3.32e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF2—coronary artery disease	5.93e-06	3.3e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK1—coronary artery disease	5.92e-06	3.29e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOA1—coronary artery disease	5.92e-06	3.29e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GSK3B—coronary artery disease	5.89e-06	3.28e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KDR—coronary artery disease	5.87e-06	3.26e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—coronary artery disease	5.85e-06	3.25e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—coronary artery disease	5.84e-06	3.25e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CREB1—coronary artery disease	5.84e-06	3.25e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KIT—coronary artery disease	5.84e-06	3.25e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK14—coronary artery disease	5.83e-06	3.24e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—JAK2—coronary artery disease	5.81e-06	3.23e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HIF1A—coronary artery disease	5.72e-06	3.18e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ESR1—coronary artery disease	5.72e-06	3.18e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL2—coronary artery disease	5.72e-06	3.18e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AGT—coronary artery disease	5.7e-06	3.17e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6R—coronary artery disease	5.7e-06	3.17e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JAK2—coronary artery disease	5.69e-06	3.16e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FN1—coronary artery disease	5.65e-06	3.14e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—F2—coronary artery disease	5.65e-06	3.14e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—coronary artery disease	5.64e-06	3.14e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6ST—coronary artery disease	5.62e-06	3.13e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1—coronary artery disease	5.62e-06	3.13e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GSK3B—coronary artery disease	5.61e-06	3.12e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAPK1—coronary artery disease	5.59e-06	3.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOE—coronary artery disease	5.58e-06	3.11e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LEP—coronary artery disease	5.58e-06	3.11e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NFKBIA—coronary artery disease	5.58e-06	3.1e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PIK3CA—coronary artery disease	5.57e-06	3.1e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—coronary artery disease	5.56e-06	3.09e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CREB1—coronary artery disease	5.56e-06	3.09e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—coronary artery disease	5.54e-06	3.08e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOA1—coronary artery disease	5.52e-06	3.07e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—coronary artery disease	5.51e-06	3.06e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KDR—coronary artery disease	5.47e-06	3.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—coronary artery disease	5.46e-06	3.04e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL2—coronary artery disease	5.44e-06	3.03e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK14—coronary artery disease	5.43e-06	3.02e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6R—coronary artery disease	5.42e-06	3.02e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KIT—coronary artery disease	5.4e-06	3.01e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1—coronary artery disease	5.35e-06	2.97e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—PIK3CA—coronary artery disease	5.34e-06	2.97e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SERPINE1—coronary artery disease	5.34e-06	2.97e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ESR1—coronary artery disease	5.33e-06	2.97e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK1—coronary artery disease	5.32e-06	2.96e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—F2—coronary artery disease	5.27e-06	2.93e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FN1—coronary artery disease	5.27e-06	2.93e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6ST—coronary artery disease	5.24e-06	2.92e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—coronary artery disease	5.2e-06	2.89e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NFKBIA—coronary artery disease	5.2e-06	2.89e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—coronary artery disease	5.19e-06	2.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GSK3B—coronary artery disease	5.19e-06	2.88e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF2—coronary artery disease	5.17e-06	2.87e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—coronary artery disease	5.14e-06	2.86e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CREB1—coronary artery disease	5.14e-06	2.86e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PIK3CA—coronary artery disease	5.14e-06	2.86e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—coronary artery disease	5.11e-06	2.84e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—coronary artery disease	5.09e-06	2.83e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—PIK3CA—coronary artery disease	5.09e-06	2.83e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SERPINE1—coronary artery disease	5.08e-06	2.82e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KIT—coronary artery disease	5.04e-06	2.8e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL2—coronary artery disease	5.03e-06	2.8e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6R—coronary artery disease	5.02e-06	2.79e-05	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—coronary artery disease	5.01e-06	2.79e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CASP3—coronary artery disease	4.97e-06	2.76e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JAK2—coronary artery disease	4.95e-06	2.75e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1—coronary artery disease	4.95e-06	2.75e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—coronary artery disease	4.94e-06	2.75e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK1—coronary artery disease	4.92e-06	2.74e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF2—coronary artery disease	4.92e-06	2.73e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—coronary artery disease	4.9e-06	2.73e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PIK3CA—coronary artery disease	4.85e-06	2.7e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—coronary artery disease	4.85e-06	2.7e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCND1—coronary artery disease	4.84e-06	2.69e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GSK3B—coronary artery disease	4.84e-06	2.69e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—coronary artery disease	4.8e-06	2.67e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CREB1—coronary artery disease	4.8e-06	2.67e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JAK2—coronary artery disease	4.71e-06	2.62e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PIK3CA—coronary artery disease	4.71e-06	2.62e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SERPINE1—coronary artery disease	4.7e-06	2.61e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—coronary artery disease	4.69e-06	2.61e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL2—coronary artery disease	4.69e-06	2.61e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6R—coronary artery disease	4.68e-06	2.6e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PIK3CA—coronary artery disease	4.62e-06	2.57e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1—coronary artery disease	4.61e-06	2.57e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—coronary artery disease	4.55e-06	2.53e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—coronary artery disease	4.55e-06	2.53e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF2—coronary artery disease	4.55e-06	2.53e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—coronary artery disease	4.52e-06	2.51e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—coronary artery disease	4.49e-06	2.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SERPINE1—coronary artery disease	4.38e-06	2.44e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—coronary artery disease	4.37e-06	2.43e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JAK2—coronary artery disease	4.36e-06	2.43e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CASP3—coronary artery disease	4.32e-06	2.41e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—coronary artery disease	4.3e-06	2.39e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—coronary artery disease	4.3e-06	2.39e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PIK3CA—coronary artery disease	4.27e-06	2.38e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF2—coronary artery disease	4.24e-06	2.36e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—coronary artery disease	4.22e-06	2.34e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCND1—coronary artery disease	4.21e-06	2.34e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—coronary artery disease	4.2e-06	2.34e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK1—coronary artery disease	4.2e-06	2.33e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—coronary artery disease	4.18e-06	2.33e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—coronary artery disease	4.15e-06	2.31e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CASP3—coronary artery disease	4.12e-06	2.29e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—coronary artery disease	4.09e-06	2.27e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—coronary artery disease	4.09e-06	2.27e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JAK2—coronary artery disease	4.07e-06	2.26e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCND1—coronary artery disease	4.01e-06	2.23e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—coronary artery disease	3.98e-06	2.21e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—coronary artery disease	3.96e-06	2.2e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—coronary artery disease	3.95e-06	2.2e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—coronary artery disease	3.89e-06	2.16e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK1—coronary artery disease	3.87e-06	2.15e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—coronary artery disease	3.87e-06	2.15e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—coronary artery disease	3.84e-06	2.14e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CASP3—coronary artery disease	3.81e-06	2.12e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK1—coronary artery disease	3.79e-06	2.11e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—coronary artery disease	3.78e-06	2.1e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—coronary artery disease	3.77e-06	2.1e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—coronary artery disease	3.71e-06	2.06e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCND1—coronary artery disease	3.71e-06	2.06e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—coronary artery disease	3.67e-06	2.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PIK3CA—coronary artery disease	3.64e-06	2.03e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—coronary artery disease	3.6e-06	2e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CASP3—coronary artery disease	3.55e-06	1.98e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—coronary artery disease	3.49e-06	1.94e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—coronary artery disease	3.49e-06	1.94e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCND1—coronary artery disease	3.46e-06	1.92e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—coronary artery disease	3.37e-06	1.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PIK3CA—coronary artery disease	3.36e-06	1.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—coronary artery disease	3.36e-06	1.87e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK1—coronary artery disease	3.3e-06	1.84e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CA—coronary artery disease	3.29e-06	1.83e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—coronary artery disease	3.23e-06	1.8e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—coronary artery disease	3.22e-06	1.79e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—coronary artery disease	3.21e-06	1.78e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK1—coronary artery disease	3.14e-06	1.75e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—coronary artery disease	3.01e-06	1.68e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—coronary artery disease	2.98e-06	1.66e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—coronary artery disease	2.97e-06	1.65e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—coronary artery disease	2.97e-06	1.65e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—coronary artery disease	2.92e-06	1.62e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK1—coronary artery disease	2.91e-06	1.62e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CA—coronary artery disease	2.87e-06	1.59e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—coronary artery disease	2.77e-06	1.54e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—coronary artery disease	2.75e-06	1.53e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CA—coronary artery disease	2.73e-06	1.52e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK1—coronary artery disease	2.71e-06	1.51e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—coronary artery disease	2.69e-06	1.5e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—coronary artery disease	2.54e-06	1.41e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CA—coronary artery disease	2.52e-06	1.4e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—coronary artery disease	2.42e-06	1.34e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CA—coronary artery disease	2.35e-06	1.31e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—coronary artery disease	2.34e-06	1.3e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—coronary artery disease	2.24e-06	1.24e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—coronary artery disease	2.23e-06	1.24e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—coronary artery disease	2.08e-06	1.16e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—coronary artery disease	2.06e-06	1.15e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—coronary artery disease	1.92e-06	1.07e-05	CbGpPWpGaD
